The chair of Winston & Strawn’s litigation practice is reportedly set to jump to Kirkland & Eliis and join its executive committee.
James Hurst, who specializes in litigation and intellectual property, has several antitrust cases under his belt – most notably, he secured a win in 2011 in defending Abbott Laboratories accused of fixing drug prices.
According to reports, while not unprecedented, it is unusual for law firms to make a lateral hire of the executive team. Kirkland says Hurst will focus on representing pharmaceutical companies that make branded drugs; Winston, on the other hand, represents several generic drug makers, so Hurt’s move will not pose a conflict of interest, reports say.
Full content: Chicago Business
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Uruguayan Antitrust Scrutiny Puts Major Meatpacking Deal Between Marfrig and Minerva on Hold
May 19, 2024 by
CPI
Alaska Airlines Seeks Dismissal of Consumer Lawsuit Over $1.9 Billion Hawaiian Airlines Buy
May 19, 2024 by
CPI
Idaho Attorney General Orders Split of Kootenai Health and Syringa Hospital
May 19, 2024 by
CPI
Court Rejects T-Mobile’s Appeal Bid in Antitrust Case Over Sprint Merger
May 19, 2024 by
CPI
Google Requests Judge, Not Jury, to Decide on Antitrust Case
May 19, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Ecosystems
May 9, 2024 by
CPI
Mapping Antitrust onto Digital Ecosystems
May 9, 2024 by
CPI
Ecosystems and Competition Law: A Law and Political Economy Approach
May 9, 2024 by
CPI
Ecosystem Theories of Harm: What is Beyond the Buzzword?
May 9, 2024 by
CPI
Open Ecosystems: Benefits, Challenges, and Implications for Antitrust
May 9, 2024 by
CPI